Raman Baweja, MD, MS

AACAP Annual Meeting 2026

October 26–31, 2026 · Atlanta, GA · Full program

• SessionChairPractical Framework for Assessing and Managing Clinically Significant Psychotropic Medication Side Effects in Children and Adolescents

  October 27, 2026, 14:00–16:00

  Offers a practical approach to recognizing and managing clinically significant side effects of psychotropic medications in youth.

  Child & AdolescentDrug Interactions & Safety

• LectureNeurological Side Effects of Psychotropic Medications in Children and Adolescents: Recognition, Management, and Clinical Implications

  October 27, 2026, 14:00–16:00

  Covers recognizing and managing neurological adverse effects of psychotropics in young patients.

  Child & AdolescentDrug Interactions & SafetyTardive Dyskinesia & Movement Disorders

• SymposiumChairUsing Measurement-Based Care to Improve Outcomes in Pediatric Psychopharmacology: Standards, Trials, and Real-World Practice

  October 27, 2026, 08:00–10:00

  Examines how measurement-based care standards, trial evidence and real-world implementation can improve pediatric psychopharmacology outcomes.

  Child & AdolescentMeasurement-Based Care & Diagnosis

• LectureDeveloping a Measurement-Based Care System for Child and Adolescent Psychiatry: The Penn State PCARES-Youth Initiative

  October 27, 2026, 08:00–10:00

  Presents the development of a measurement-based care system in child and adolescent psychiatry at Penn State.

  Child & AdolescentMeasurement-Based Care & Diagnosis

• CoursePediatric Psychopharmacology and Neurotherapeutics: The When and How of Initiating and Discontinuing Interventions

  October 28, 2026

  Institute organized around starting and stopping treatment across antidepressants, antipsychotics, and stimulants, plus pediatric ECT and the psychotherapeutic dimensions of prescribing, with faculty including Graham Emslie and Robert Findling.

  Antipsychotic PrescribingChild & AdolescentDeprescribing & PolypharmacyNeuromodulation (ECT, TMS)

• LectureUpdates in Stimulant Pharmacotherapy for ADHD: Recent Evidence and Clinical Considerations in Special Populations

  October 28, 2026, 12:00–14:00

  Reviews recent evidence on stimulant treatment for ADHD and considerations for special populations.

  ADHDChild & AdolescentStimulants & ADHD Medications

• PosterADHD Pharmacotherapy in the Context of Depression: Real-World Treatment Patterns and Clinical Outcomes Among Youth and Young Adults

  October 28, 2026, 13:00–15:00

  Poster describing real-world ADHD medication treatment patterns and outcomes in youth and young adults who also have depression.

  ADHDChild & AdolescentDepressionStimulants & ADHD Medications

• SymposiumADHD Treatment in the Real World: Outcomes, Comorbidities, and Clinical Decision-Making

  October 29, 2026

  Symposium on real-world ADHD treatment outcomes and decision-making in the presence of comorbidity, led by prominent ADHD trialists including Jeffrey Newcorn and Margaret Weiss.

  ADHDChild & AdolescentStimulants & ADHD Medications

• LectureImpact of Comorbid ASD on Treatment and Clinical Outcomes of ADHD

  October 29, 2026, 14:30–16:30

  Examines how co-occurring autism spectrum disorder affects treatment response and outcomes in ADHD.

  ADHDAutism & Neurodevelopmental Disorders

• LectureThe Impact of DMDD on Treatment Trajectories and Outcomes in Youth With ADHD and Internalizing Comorbidities

  October 29, 2026, 14:30–16:30

  Looks at how disruptive mood dysregulation disorder shapes treatment course and outcomes in youth with ADHD and internalizing comorbidities.

  ADHDChild & Adolescent

• LecturePredictors of ADHD Medication Use in Youth and Adults With Co-occurring Substance Use Disorders

  October 29, 2026, 14:30–16:30

  Explores factors associated with ADHD medication use among youth and adults who also have substance use disorders.

  ADHDStimulants & ADHD MedicationsSubstance Use Disorders

• PosterPsychotherapy Access in Children and Adolescents With Behavioral Health Diagnoses: A Large, Multisite, Electronic Health Record–Based Study

  October 29, 2026, 10:30–12:30

  Multisite electronic health record study of access to psychotherapy among youth with behavioral health diagnoses.

  Child & AdolescentPractice, Policy & WorkforcePsychotherapy

• WorkshopChairComplex ADHD in Youth: Assessment and Management Across Comorbidities and Developmental Profiles

  October 31, 2026, 07:00–08:30

  Case-based breakfast consultation on assessing and managing youth with ADHD who also have mood, anxiety, irritability, trauma, autism or substance use concerns. Covers combined pharmacologic and psychosocial strategies adapted to developmental stage and tolerability.

  ADHDAutism & Neurodevelopmental DisordersChild & AdolescentStimulants & ADHD Medications